Are you a product developer, healthcare professional, patient or researcher interested in contributing to future research in respiratory disease?
The MedTech Navigator is a programme that will facilitate knowledge exchange between industry, the NHS and academia. The programme will enable the development of novel medical technologies that will improve healthcare and quality of life for patients.
The first in a series of themed events, this workshop will focus on respiratory disease and explore opportunities for collaborative product development and research and identify key areas that could be further developed into funding applications. Some of the key conditions that will be explored include COPD, asthma and lung cancer.
The workshop will include presentations from clinicians who will share the major clinical challenges and unmet needs related to respiratory diseases. Delegates will also hear from companies at the forefront of developing innovative solutions in this growing field.
Key objectives of the day:
- Exchange of information, insights and knowledge between industry and the NHS.
- Enable companies to identify potential market opportunities in respiratory disease and apply for Innovation Grant funding through the programme.
- Engaging SMEs in new R&D projects that are both customer-focussed and collaborative in nature.
- Creation of partnerships between clinicians, academics and industry to develop the right products for the healthcare market of the future.
The event will also see the launch of two white papers, covering the health economics and industry landscape for respiratory disease respectively.
Venue and Refreshments: This event will be held at the Rowley Mile Racecourse, Cambridge Road, Newmarket, CB8 0TF. Refreshments and lunch will be provided.
Register: Please note this is a free event and pre-registration is essential. To book your place please visit the event page here.
For more information please contact Dr Evangelia Vezouviou at firstname.lastname@example.org or Tel: 01223 928041
This project is part-funded by the European Regional Development Fund (ERDF).